P

Inventor

MANNING ROBERT E

68 patents
⚠️ This page may combine multiple inventors who share the name “MANNING ROBERT E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SEARLE & CO

38 patents
US6943189B2Sep 13, 2005

Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitors

SEARLE & CO78 citations97
US5393790AFeb 28, 1995

Substituted spiro compounds for the treatment of inflammation

SEARLE & CO212 citations97
US5087634AFeb 11, 1992

N-substituted imidazol-2-one compounds for treatment of circulatory disorders

SEARLE & CO79 citations96
US5861420AJan 19, 1999

N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders

SEARLE & CO25 citations93
US5674879AOct 7, 1997

Compositions including and methods of using conformationally restricted angiotensin II antagonist

SEARLE & CO35 citations93
US5426105AJun 20, 1995

Conformationally restricted angiotensin II antagonists

SEARLE & CO37 citations93
US4923874AMay 8, 1990

Use of 8-azapurin-6-one derivatives for control of hypertension

SEARLE & CO79 citations93
US6642268B2Nov 4, 2003

Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors

SEARLE & CO22 citations92
US6420417B1Jul 16, 2002

Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors

SEARLE & CO37 citations92
US6268392B1Jul 31, 2001

Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors

SEARLE & CO37 citations92
US6008368ADec 28, 1999

Pharmaceutical compositions for treatment of circulatory disorders using N-substituted (α-imidazolyl-toluyl) pyrrole aniotensin II antagonists

SEARLE & CO25 citations92
US5981511ANov 9, 1999

Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors

SEARLE & CO24 citations92
US5945408AAug 31, 1999

Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors

SEARLE & CO27 citations92
US5451597ASep 19, 1995

Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists

SEARLE & CO22 citations92
US5106834AApr 21, 1992

Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents

SEARLE & CO37 citations90
US5441970AAug 15, 1995

Use of N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders

SEARLE & CO19 citations82
US6630497B2Oct 7, 2003

1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders

SEARLE & CO7 citations74
US5416084AMay 16, 1995

Benzo-fused thiomorpholinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO2 citations74
US5411959AMay 2, 1995

1,4-Thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO2 citations74
US5411954AMay 2, 1995

Benzo-fused oxazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO3 citations74
US5411961AMay 2, 1995

Benzo-fused morpholinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO3 citations74
US5409925AApr 25, 1995

Oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO2 citations74
US5302610AApr 12, 1994

Renal-selective biphenylmethyl imidazole angiotensin II antagonists for treatment of hypertension

SEARLE & CO9 citations74
US5217985AJun 8, 1993

Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension

SEARLE & CO16 citations74
US5736579AApr 7, 1998

Substituted spiro compounds for the treatment of inflammation

SEARLE & CO8 citations72
US6858636B2Feb 22, 2005

1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders

SEARLE & CO2 citations63
US5484937AJan 16, 1996

N-substituted N-(α-triazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders

SEARLE & CO3 citations63
US5413998AMay 9, 1995

Benzo-fused thiazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO1 citations63
US5411953AMay 2, 1995

Oxazopinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO1 citations63
US5411975AMay 2, 1995

Thiazolidinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO1 citations63
US5411950AMay 2, 1995

Benzo-fused oxazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO1 citations63
US5409945AApr 25, 1995

Benzyo-fused thiazolidinyl terminated alkylamino ethylnyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO1 citations63
US5409921AApr 25, 1995

Thiazetidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO1 citations63
US5409922AApr 25, 1995

Thiozopinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO1 citations63
US5409924AApr 25, 1995

Benzo-fused oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO1 citations63
US5373017ADec 13, 1994

Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO3 citations63
US5252591AOct 12, 1993

Pyridinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

SEARLE & CO3 citations63
US5238952AAug 24, 1993

N-substituted imidazol-2-one compounds for treatment of circulatory disorders

SEARLE & CO3 citations63

SANDOZ AG

5 patents

PHARMACIA CORP

2 patents

CANNON INSTR COMPANY

2 patents

BRUNSWICK CORP

1 patent

KEANE J TIMOTHY

1 patent

MANNING ROBERT E

1 patent

Showing the top 50 of 68 patents by PatentIndex Score.